Matinas BioPharma Announces Initiation of ENHANCE-IT Study of MAT9001 Against Vascepa®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/29/2026

1. LFTO
2. CMCSA
3. QNT
4. VRDN
5. NVDA
6. INIO
7. HONA
8. ABBV
9. HON
10. SPY

Go back to Matinas BioPharma Announces Initiation of ENHANCE-IT Study of MAT9001 Against Vascepa®
(NYSE: MTNB) Delayed: 0.66 +0.02 (3.13%)
Previous Close $0.64    52 Week High $2.01 
Open $0.62    52 Week Low $0.41 
Day High $0.67    P/E N/A 
Day Low $0.62    EPS $0.00 
Volume 58,415